Most intriguingly, this insertion occurred in a pediatric SCID-X1 patient who developed a leukaemia secondary to retroviral reinsertion (in front of LMO2, a known TAL1-cooperating oncogene) following gene therapy16. This evidence concerns the gene TAL1 and leukemia.